Cet anticorps Lapin Polyclonal détecte spécifiquement BCL2L1 dans WB. Il présente une réactivité avec des échantillons de Humain et Rat.Il a été cité dans 1 publication.
This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogène
This BCL2L1 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 195-229 amino acids from the C-terminal region of human BCL2L1.
BCL2L1
Reactivité: Humain, Souris, Rat
WB, IHC, IF, ELISA, ICC
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
WB: 1:1000
Restrictions
For Research Use only
Format
Liquid
Buffer
Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
4 °C,-20 °C
Date de péremption
6 months
Hu, Kuo, Senadi, Chang, Wang: "Photodynamic Therapy Using Indolines-Fused-Triazoles Induces Mitochondrial Apoptosis in Human Non-Melanoma BCC Cells." dans: Anticancer research, Vol. 37, Issue 10, pp. 5499-5505, (2017) (PubMed).
Antigène
BCL2L1
(BCL2-Like 1 (BCL2L1))
Autre désignation
BCL2L1
Sujet
Potent inhibitor of cell death. Inhibits activation of caspases. Appears to regulate cell death by blocking the voltage- dependent anion channel (VDAC) by binding to it and preventing the release of the caspase activator, CYC1, from the mitochondrial membrane. Also acts as a regulator of G2 checkpoint and progression to cytokinesis during mitosis. Isoform Bcl-X(S) promotes apoptosis.